DE60203997D1 - Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat - Google Patents

Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat

Info

Publication number
DE60203997D1
DE60203997D1 DE60203997T DE60203997T DE60203997D1 DE 60203997 D1 DE60203997 D1 DE 60203997D1 DE 60203997 T DE60203997 T DE 60203997T DE 60203997 T DE60203997 T DE 60203997T DE 60203997 D1 DE60203997 D1 DE 60203997D1
Authority
DE
Germany
Prior art keywords
paroxetine hydrochloride
wet granulation
preparation
pharmaceutical tablets
hydrochloride anhydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60203997T
Other languages
English (en)
Other versions
DE60203997T2 (de
Inventor
Christian Felumb
Lund Henriksen
Bols Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AS
Original Assignee
GEA Farmaceutisk Fabrik AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEA Farmaceutisk Fabrik AS filed Critical GEA Farmaceutisk Fabrik AS
Publication of DE60203997D1 publication Critical patent/DE60203997D1/de
Application granted granted Critical
Publication of DE60203997T2 publication Critical patent/DE60203997T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60203997T 2001-03-02 2002-03-01 Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat Expired - Fee Related DE60203997T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
DK200100341 2001-03-02
PCT/DK2002/000134 WO2002069969A1 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate

Publications (2)

Publication Number Publication Date
DE60203997D1 true DE60203997D1 (de) 2005-06-09
DE60203997T2 DE60203997T2 (de) 2006-02-23

Family

ID=8160333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203997T Expired - Fee Related DE60203997T2 (de) 2001-03-02 2002-03-01 Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat

Country Status (11)

Country Link
US (1) US20040072912A1 (de)
EP (1) EP1363633B1 (de)
AT (1) ATE294580T1 (de)
AU (1) AU2002233182B2 (de)
CA (1) CA2439460A1 (de)
DE (1) DE60203997T2 (de)
DK (2) DK200100341A (de)
ES (1) ES2239707T3 (de)
NO (1) NO20033855D0 (de)
PT (1) PT1363633E (de)
WO (1) WO2002069969A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162458A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040208932A1 (en) * 2003-04-17 2004-10-21 Ramachandran Thembalath Stabilized paroxetine hydrochloride formulation
WO2005034954A2 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
WO2006076797A1 (en) * 2005-01-19 2006-07-27 Merck Frosst Canada Ltd. Cathepsin k inhibitors and atherosclerosis
JP5153629B2 (ja) * 2005-08-02 2013-02-27 ルピン・リミテッド 選択的セロトニン再取り込み阻害剤の新規の制御放出組成物
CN113350350A (zh) * 2020-03-07 2021-09-07 齐鲁制药有限公司 一种含有盐酸培唑帕尼的药物组合物的制备方法
CN113730369B (zh) * 2020-05-27 2023-07-14 石药集团欧意药业有限公司 一种阿哌沙班片剂组合物及其制备方法
WO2024088560A1 (en) * 2022-10-28 2024-05-02 Roquette Freres Compound for formulating moisture sensitive active ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149266B1 (de) * 1983-12-19 1988-05-18 Duphar International Research B.V Verfahren zum Trocknen von festen Stoffen und Vorrichtung zu dessen Ausführung
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
US6645523B2 (en) * 2000-08-28 2003-11-11 Synthon Bct Technologies, Llc Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
EP1363633B1 (de) 2005-05-04
ES2239707T3 (es) 2005-10-01
NO20033855L (no) 2003-09-01
PT1363633E (pt) 2005-09-30
AU2002233182B2 (en) 2004-10-14
US20040072912A1 (en) 2004-04-15
WO2002069969A1 (en) 2002-09-12
DK1363633T3 (da) 2005-05-30
DE60203997T2 (de) 2006-02-23
DK200100341A (da) 2002-09-03
NO20033855D0 (no) 2003-09-01
ATE294580T1 (de) 2005-05-15
CA2439460A1 (en) 2002-09-12
EP1363633A1 (de) 2003-11-26

Similar Documents

Publication Publication Date Title
DE60008912D1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
ZA992951B (en) N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders.
WO2001087839A8 (en) Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
FI870588A0 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
DK1140745T3 (da) Colchinolderivater som vaskulært skadelige midler
RU2000123156A (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
DK1246622T3 (da) Nye substituerede benzimidazol dosisformer og metoder til deres anvendelse
WO2002012242A3 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
EA200001201A2 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
DE60203997D1 (de) Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
BR9709858A (pt) Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto
SE0102440D0 (sv) New compound
EP0337136A3 (de) Piperidin-Derivate für die Behandlung von Nebenwirkungen bei der neuroleptischen Therapie
HRP20020181B1 (hr) Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak
GR1004193B (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
RU2002135669A (ru) Олигопептиды
PE20040916A1 (es) Diamidas de acido pirimidin-4,6-dicarboxilico como inhibidores selectivos de mmp-13
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
NO20024363L (no) Nye LHRH-antagonister, produksjon og anvendelse av disse som medikamant
AR008695A1 (es) Composiciones farmaceuticas estabilizadas, basadas en la asociacion de quinupristina / dalfopristina; procedimiento para prepararlas, utilizacion dedichas composiciones y utilizacion del acido metansulfonico o del acido clorhidrico en la estabilizacion de dichas composiciones.
PT89105A (pt) Processo para a preparacao de composicoes farmaceuticas contendo tetraciclina
DK472886A (da) Fremgangsmaade til fremstilling af et granulat ved samtidig toerringog granulering af ekstraktstoffer fra for aeggehvidestof befriet kalveblod og anvendelse af granulatet til fremstilling af farmaceutiske praeparater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee